Granules enters into strategic alliance with Heritage

Mumbai, July 5 (UNI) Granules India Ltd, a pharmaceutical ingredients manufacturer, has entered into a strategic alliance with US-based Heritage Pharmaceuticals Inc for manufacturing, supply and marketing of generic pharmaceutical products for the US prescription drug market.

Under the Agreement, Granules will develop and register selected products for US Abbreviated New Drug Application (ANDA) submission and Heritage will retain exclusive sales and marketing rights to such products, the company said in a statement.

Commenting on the deal, C. Krishna Prasad, Managing Director, Granules, said, ''This is in line with our overall strategy for partnering with prescription product marketers on a development and manufacturing agreement.'' Granules manufactures several strategic active pharmaceutical ingredients (APIs) and multiple pharmaceutical formulation intermediates (PFIs), which are distributed in 35 countries, the statement added.

UNI